Robby Wu, DO
Cardiovascular Disease · Tampa, FLNPI 1659614451
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $141,441 of the $190,062 with a category attached, or 74.4%. E.r. Squibb & Sons, L.L.C. accounts for 87.4% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $92,569, more than ten times the $8,073 reported in 2019. Among cardiovascular disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 419 payments — averaging $453.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$166K
- Abbott$13K
- Biotronik Inc.$2K
- Abiomed$2K
- Medtronic$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$778
- plus $4K from 24 others
Across 14 payments — averaging $20,706 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Procyrion, Inc.$263K
- Lexicon Pharmaceuticals, Inc.$27K
What the payments were for
- Consulting fees$14,2658%
- Speaking & faculty fees$141,44174%
- Travel & lodging$15,2388%
- Food & beverage$18,87010%
- Education$2480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 131 | $166,059 |
| Abbott | 185 | $13,194 |
| Biotronik Inc. | 4 | $2,308 |
| Abiomed | 18 | $2,194 |
| Medtronic | 5 | $1,205 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $778 |
| AstraZeneca | 9 | $720 |
| Procyrion, Inc. | 4 | $600 |
| Cvrx, Inc. | 6 | $490 |
| Ancora Heart, Inc. | 4 | $416 |
| Endotronix, Inc. | 2 | $244 |
| Johnson & Johnson | 8 | $209 |
| Astellas Pharma US Inc | 2 | $198 |
| Edwards Lifesciences | 2 | $180 |
| Itamar Medical Inc | 1 | $146 |
| Alnylam Pharmaceuticals Inc. | 2 | $129 |
| Daxor Corporation | 1 | $128 |
| Amgen | 1 | $122 |
| Bayer | 1 | $122 |
| Actelion Pharmaceuticals US, Inc. | 1 | $121 |
| Bridgebio Pharma, Inc. | 1 | $120 |
| Mallinckrodt Hospital Products Inc. | 1 | $94 |
| Pfizer | 4 | $77 |
| Merck | 1 | $63 |
| Boehringer Ingelheim | 3 | $42 |
| Biosense Webster, Inc. | 1 | $31 |
| One Lambda, Inc. | 1 | $24 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$156,601
- CARDIOMEMS$5,379
- Impella$1,880
- HeartMate PHP$1,090
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$730
- CardioMEMS HF System$683
- AORTIX SYSTEM$508
- Barostim Neo System$451
- FARXIGA$364
- MitraClip System$299
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$244
- AccuCinch$218
- Ensite Cardiac Mapping System$170
- TactiCath Quartz CFA Catheter$166
- AMPLATZER Occluders$157
- Assurity Pacemaker$152
- Edwards SAPIEN 3 Transcatheter Heart Valve$150
- WatchPATONE$146
- Connect HF$144
- BRILINTA$134
How this compares
$190,062 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CamzyosMavacamten | 166 | $1,352,468 |
| VyndamaxTafamidis | 18 | $840,270 |
| FarxigaDapagliflozin Propanediol | 179 | $204,531 |
| EntrestoSacubitril/Valsartan | 140 | $189,713 |
| EliquisApixaban | 61 | $78,132 |
| JardianceEmpagliflozin | 35 | $49,414 |
| OzempicSemaglutide | 31 | $34,418 |
| XareltoRivaroxaban | 19 | $28,597 |
| CorlanorIvabradine Hcl | 21 | $19,730 |
| Repatha SureclickEvolocumab | 17 | $14,710 |
| Metoprolol Succinate | 159 | $2,657 |
| Eplerenone | 16 | $2,057 |
| Ezetimibe | 60 | $1,774 |
| Dofetilide | 14 | $1,591 |
| Rosuvastatin Calcium | 77 | $1,402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Camzyos | $166,059 | $1,352,468166 claims |
| PfizerVyndamax, Eliquis | $77 | $918,40279 claims |
| AstraZenecaFarxiga | $720 | $204,531179 claims |
| NovartisEntresto | $13 | $189,713140 claims |
| Boehringer IngelheimJardiance | $42 | $49,41435 claims |
| Johnson & JohnsonXarelto | $209 | $28,59719 claims |
| AmgenCorlanor | $122 | $19,73021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Tampa
- Hiram BezerraTampa$698K
- James SmithTampa$324K
- David WilsonTampa$258K
- Jason FelibertiTampa$138K
- Samip VasaiwalaTampa$126K
- Kevin MakatiLutz$1.6M
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.